Figure 1.
Survival curves between α-fetoprotein-producing gastric cancer and α-fetoprotein-non producing gastric cancer. The postoperative cause-specific 5-year survival rate of patients with α-fetoprotein (AFP)-producing gastric cancer (GC) was significantly poorer than that of patients without AFP-producing GC (5-year survival rate: 50.3% and 76.5%, P = 0.002).